Skip to Main Content

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

This study has been completed.

Sponsor:

Collaborator:

Formulario MAgistral Farmacias Ahumada

Information provided by:

Pontificia Universidad Catolica de Chile

ClinicalTrials.gov Identifier:

NCT00438048

First received: February 20, 2007

Last updated: May 21, 2008

Last verified: May 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2008
Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)

Publications:

Wu CH, Hsieh SC, Lee KL, Li KJ, Lu MC, Yu CL. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjogren's syndrome in Taiwan--a double-blind, placebo-controlled trial. J Formos Med Assoc. 2006 Oct;105(10):796-803.

Brito-Zeron P, Ramos-Casals M, Nardi N, Font J. [Results of the treatment with oral pilocarpine in 100 patients with primary Sjogrens syndrome] Med Clin (Barc). 2006 Apr 29;126(16):637. Spanish. No abstract available.

Aframian DJ, Helcer M, Livni D, Markitziu A. Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer. Oral Dis. 2006 May;12(3):297-300.

Aragona P, Di Pietro R, Spinella R, Mobrici M. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome. Br J Ophthalmol. 2006 Feb;90(2):166-70.